CAS No 1263774-59-9 Delgocitinib Pharmaceutical Intermediates

Product name	Delgocitinib
CAS No.	1263774-59-9
EINECS	/
Formula	C16H18N6O
Molecular Weight	310.35
Appearance	White to off-white Solid
Purity	≥98%
Type	Pharmaceutical Intermediates

High Purity: Our Degocitinib is manufactured to strict quality standards, ensuring high purity and efficacy for pharmaceutical applications.

Innovative therapeutic drugs: Digotinib is a novel oral Janus kinase (JAK) inhibitor, mainly used to treat autoimmune diseases, including atopic dermatitis and rheumatoid arthritis.

Reliable supply chain: As an integrated production and trading factory, we guarantee a continuous and reliable supply of Degotinib to meet your needs.

Advanced Manufacturing: Our state-of-the-art production facilities utilize advanced technology to ensure the highest quality of our products.

Regulatory Compliance: Our Delgocitinib complies with all relevant pharmaceutical regulations, ensuring safety and efficacy for the end-user.

Customized Solutions: We offer customized solutions including bulk orders and custom packaging to meet our customers' specific requirements.

product details

Product details

introduce

Degocitinib is a highly selective oral Janus kinase (JAK) inhibitor that shows promise in treating a variety of autoimmune diseases. By inhibiting the JAK pathway, Degocitinib is effective in modulating immune responses, reducing inflammation and alleviating symptoms associated with diseases such as atopic dermatitis and rheumatoid arthritis. This innovative therapeutic is designed to provide targeted treatment, offering patients a new option for managing their disease. Our Degocitinib is manufactured in a controlled environment, ensuring it meets the highest quality and performance standards, making it a trusted choice for healthcare providers and pharmaceutical manufacturers.

Physical and chemical properties

Degocitinib has unique physical and chemical properties that contribute to its effectiveness as a therapeutic agent:

- Molecular formula: C16H18N6O

- Molecular weight: 310.35g/mol

- Appearance: White to off-white Solid

- Solubility: Soluble in dimethyl sulfoxide (DMSO) and methanol; slightly soluble in water

- pH: pH in aqueous solution is usually between 5.0 and 7.0

- Stability: Stable under normal storage conditions, shelf life up to 24 months when properly stored.

These properties make degotinib an effective option for the treatment of autoimmune diseases, providing healthcare professionals with a reliable option for patient care.

advantage

- Anti-inflammatory effect: Clinical studies have shown that dichotinib can effectively reduce inflammation and related symptoms, thereby improving the treatment outcome of patients with autoimmune diseases.
- Selective JAK inhibition: Compared with non-selective JAK inhibitors, dichotinib selectively targets specific JAK enzymes, minimizing off-target effects and improving safety.
- Easy to use: Digotinib is in the form of oral tablets, which are easy to administer and improve patient compliance and convenience.
- Expert Manufacturing Practices: Our facility uses advanced manufacturing techniques and stringent quality control measures to ensure that every batch of Digotinib meets the highest standards of purity and efficacy.
- Committed to customer satisfaction: We prioritize our customers' needs and provide personalized support and solutions based on the specific requirements of the pharmaceutical industry.

Uses in the pharmaceutical industry

In summary, Delgocitinib is an important drug for the treatment of autoimmune diseases, providing a new approach to controlling inflammation and immune responses. Our commitment to quality, reliability, and customer satisfaction makes us a trusted partner for pharmaceutical manufacturers and healthcare providers. Whether you need a bulk order or a custom solution, our Delgocitinib is an ideal choice to meet your needs. Contact us today to learn more about our products and how we can support your business in the pharmaceutical field.